Abbott Laboratories

Abbott Laboratories

2,010.00
MXN
0.00
(0.00%)
3.18TMarket Cap
Jan 27Next Earn

Total Valuation

MXN

As of September 30, 2026, Abbott Laboratories carries a market capitalization of 3.18T, placing it among publicly traded companies globally. Its enterprise value stands at 3.67T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.18T
Enterprise Value3.67T

Important Dates

Abbott Laboratories's next confirmed earnings release is scheduled for January 27, 2027.

Earnings Date1/27/2027

Share Statistics

As of September 30, 2026, Abbott Laboratories has 1.73B shares outstanding.

Shares Outstanding1.73B

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio3.45
P/TBV Ratio-145.69

Financial Position

As of September 30, 2026, Abbott Laboratories maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.45
Quick Ratio1.00
Debt / Equity60.36

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count115,000.00

Taxes

MXN

Over the twelve months ended September 30, 2026, Abbott Laboratories recorded 22.84B in income tax expense.

Income Tax22.84B

Stock Price Statistics

MXN

As of the close on November 13, 2026, Abbott Laboratories's stock has declined approximately 14.97% over the past 52 weeks. The 50-day moving average sits at 1,881.07, while the 200-day moving average is 1,798.66.

52-Week Price Change-14.97%
50-Day Moving Average1,881.07
200-Day Moving Average1,798.66

Balance Sheet

MXN

As of September 30, 2026, Abbott Laboratories holds 77.61B in cash and equivalents against 562.64B in total debt, resulting in a net debt position of 489.47B. Total book value stands at 921.40B, with working capital of 132.61B providing operational flexibility.

Cash & Cash Equivalents77.61B
Total Debt562.64B
Net Debt489.47B
Equity (Book Value)921.40B
Book Value Per Share532.00
Working Capital132.61B

Cash Flow

MXN

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-28.91B

Dividends & Yields

MXN

Over the twelve months ended September 30, 2026, Abbott Laboratories paid dividends of 33.48 per share.

Dividend Per Share33.48

Stock Splits

Abbott Laboratories's most recent stock split took place on June 1, 1998 with a 1:2 split ratio.

Last Split Date6/1/1998
Split Ratio1:2